News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
233 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
2 (150)
3 (233)
4 (146)
7 (254)
8 (191)
9 (132)
10 (117)
11 (95)
14 (127)
15 (157)
16 (116)
17 (129)
18 (81)
22 (194)
23 (129)
24 (127)
25 (88)
28 (143)
29 (152)
30 (137)
31 (169)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
7
8
9
10
11
14
15
16
17
18
22
23
24
25
28
29
30
31
Lone Star Bio
OxySure™ Systems, Inc. Affiliates Convert $2.02 Million in Notes to Common Stock at $1.50 Per Share Conversion Price Represents 52% Premium to Market
January 3, 2013
·
1 min read
Deals
ThermoGenesis Announces Sale of Thermoline Product Line to Helmer Scientific
January 3, 2013
·
1 min read
Pharm Country
TG Therapeutics, Inc. Announces FDA Clearance to Commence Clinical Trials of Its Novel, PI3K-Delta Specific Inhibitor, TGR-1202, Under Its Recently Filed U.S. Investigational New Drug (IND) Application
January 3, 2013
·
1 min read
Given Imaging Ltd. Launches New ManoView ESO v3.0 Software
January 3, 2013
·
6 min read
Genetown
PolyRemedy, Inc. Announces Results of Clinical Study and Releases New HealSmart Software
January 3, 2013
·
2 min read
Biotech Beach
Apricus Biosciences Announces Corporate Goals for 2013
January 3, 2013
·
1 min read
FDA
BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test
January 3, 2013
·
1 min read
Policy
Sensimed AG Receives a New Reimbursement Code in the USA by the American Medical Association for Intraocular Pressure Monitoring
January 3, 2013
·
2 min read
BioMidwest
Sagent Pharmaceuticals, Inc. Announces the Launch of Flumazenil Injection, USP
January 3, 2013
·
1 min read
Business
Endologix Inc. Appoints Shelley B. Thunen Chief Financial Officer
January 3, 2013
·
1 min read
Previous
4 of 24
Next